Moolec Science (MLECW) Other Non-Current Assets (2023 - 2024)

Moolec Science (MLECW) posted Other Non-Current Assets of $25453.0 for Q4 2024, down 86.64% sequentially from $190517.0 in Q2 2024.

Moolec Science (MLECW) Other Non-Current Assets (2023 - 2024) Analysis & Trends

Moolec Science has reported Other Non-Current Assets for 2 years, with the latest figure at $25453.0 in Q4 2024.

Quarterly Other Non-Current Assets changed N/A year-over-year to $25453.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $25453.0 (changed N/A YoY) and the FY2024 annual result came in at $190517.0, changed N/A from the prior year.
Other Non-Current Assets slipped to $25453.0 in Q4 2024 per MLECW's latest filing, from $190517.0 in the prior quarter.
Over five years, Other Non-Current Assets peaked at $5.0 million in Q1 2023 and troughed at $25453.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	1.25 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	2.31 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	124.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	618.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	109.58 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	65.13 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	202.31 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	104.44 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	62.96 Mn
10	Moolec Science	8,617.72	-1.19 Mn	-	-

Download Data